[1]孙光文 徐仕皓 王媛媛 毛瑞 杨文琼.PTX3联合LP-PLA2水平与急性缺血性脑卒中合并颈动脉狭窄的关系[J].卒中与神经疾病杂志,2023,30(03):273-277.[doi:10.3969/j.issn.1007-0478.2023.03.008]
　Sun Guangwen*,Xu Shihao,Wang Ruanruan,et al.Correlation analysis of PTX3 combined with LP-PLA2 in carotid stenosis in acute ischemic stroke[J].Stroke and Nervous Diseases,2023,30(03):273-277.[doi:10.3969/j.issn.1007-0478.2023.03.008]
点击复制

PTX3联合LP-PLA2水平与急性缺血性脑卒中合并颈动脉狭窄的关系()
分享到：

《卒中与神经疾病》杂志[ISSN:1007-0478/CN:42-1402/R]

卷:
第30卷
期数:
2023年03期
页码:
273-277
栏目:
论著
出版日期:
2023-06-20

文章信息/Info

Title:
Correlation analysis of PTX3 combined with LP-PLA2 in carotid stenosis in acute ischemic stroke
文章编号:
1007-0478(2023)03-0273-05
作者:
孙光文 徐仕皓 王媛媛 毛瑞 杨文琼
442008 锦州医科大学国药东风总医院研究生培养基地(孙光文); 湖北医药学院附属国药东风总医院神经内科[徐仕皓 王媛媛 毛瑞 杨文琼(通信作者)]
Author(s):
Sun Guangwen*;  Xu Shihao;  Wang Ruanruan;  et al.
* Neurological Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan Hubei 442008
关键词:
急性缺血性脑卒中; 颈动脉粥样硬化; 正五聚蛋白3; 脂蛋白相关磷脂酶A2; 颈动脉狭窄
Keywords:
Acute ischemic stroke; Carotid atherosclerosis; Pentraxins; Lipoprotein associated phospholipid A2; Carotid stenosis
分类号:
R743.3
DOI:
10.3969/j.issn.1007-0478.2023.03.008
文献标志码:
A
摘要:
目的 探讨血浆正五聚蛋白(Pentraxins,PTX3)联合脂蛋白相关磷脂酶A2(Lipoprotein associated phospholipid A2,LP-PLA2)水平与急性缺血性脑卒中(Acute ischemic stroke,AIS)合并颈动脉狭窄的关系。方法 选择127例AIS患者,根据全脑血管造影表现分为AIS合并颈动脉狭组97例与AIS无颈动脉狭窄组30例; 根据颈动脉狭窄程度分为轻度狭窄组(n=32)、中度狭窄组(n=32)和重度狭窄组(n=33)。另选取同期体检健康者62例为对照组。采用酶联免疫吸附测定法检测所有研究对象的血浆PTX3,LP-PLA2水平; Logistic回归分析血清PTX3,LP-PLA2水平对AIS颈动脉狭窄程度的影响。结果 AIS合并颈动脉狭窄组血浆PTX3,LP-PLA2水平高于对照组及无颈动脉狭窄组(P<0.05); AIS伴颈动脉重度狭窄组血浆PTX3,LP-PLA2水平高于中度狭窄组及轻度狭窄组(P<0.005)。中重度脑卒中组血浆PTX3,LP-PLA2水平高于轻度脑卒中组(P<0.05)。多因素Logistics回归分析显示,PTX3,LP-PLA2水平是AIS合并颈动脉狭窄的影响因素(P<0.05)。结论 AIS患者血浆PTX3,LP-PLA2表达水平与颈动脉狭窄、神经功能缺损严重程度有关。
Abstract:
ObjectiveTo investigate the relationship between carotid artery stenosis and plasma pentraxins(PTX3)and lipoprotein- associated phospholipase A2(LP-PLA2)in patients with acute ischemic stroke(AIS).Methods According to the results of whole cerebral angiography, 127 patients with AIS were divided into AIS with carotid artery stenosis group(n=97)and AIS without carotid artery stenosis group(n=30). The degree of carotid stenosis was divided into mild stenosis group(n=32), moderate stenosis group(n=32)and severe stenosis group(n=33), and 62 healthy controls were selected in the same period. The plasma levels of PTX3 and LP-PLA2 were measured by enzyme-linked immunosorbent assay(Elisa), and the levels of PTX3 and LP-PLA2 in AIS group were compared. The levels of plasma PTX3 and LP-PLA2 in control group and mild, moderate and severe carotid stenosis groups. Logistic regression analysis was used to examine the effect of serum PTX3 and LP-PLA2 levels on the degree of carotid artery stenosis in AIS.Results The levels of plasma PTX3 and LP-PLA2 in AIS with carotid stenosis group were higher than those in control group and non-carotid stenosis group(P<0.05). The levels of recombinant plasma PTX3 and LP-PLA2 in AIS with severe carotid stenosis group were higher than those in moderate stenosis group and mild stenosis group(P<0.005), and the levels of plasma PTX3 and LP-PLA2 in high NIHSS score group were higher than those in low group(P<0.005). Multivariate Logistics regression analysis showed that PTX3 and LP-PLA2 were independent influencing factors of AIS and carotid stenosis.Conclusion The level of plasma PTX3 and LP-PLA2 expression in patients with AIS is closely related to carotid artery stenosis and the severity of neurological impairment.

参考文献/References:

[1] Ministrini S,Carbone F,Montecucco F.Updating concepts on atherosclerotic inflammation: from pathophysiology to treatment[J].Eur J Clin Invest,2021,51(5):e13467.
[2] Casula M,Montecucco F,Bonaventura A,et al.Update on the role of Pentraxin 3 in atherosclerosis and cardiovascular diseases[J].Vascul Pharmacol,2017:1-12.
[3] Wilensky RL,Macphee CH.Lipoprotein-associated phospholipase A(2)and atherosclerosis[J].Curr Opin Lipidol,2009,20(5):415-420.
[4] Zhao YF,Zhang XJ,Chen XY,et al.Neuronal injuries in cerebral infarction and ischemic stroke: from mechanisms to treatment(Review)[J].Int J Mol Med,2022,49(2):15.
[5] 钟迪,张舒婷,吴波.《中国急性缺血性脑卒中诊治指南2018》解读[J].中国现代神经疾病杂志,2019,19(11):897-901.
[6] Coveney S,McCabe JJ,Murphy S,et al.Anti-inflammatory therapy for preventing stroke and other vascular events after ischaemic stroke or transient ischaemic attack[J].Cochrane Database Syst Rev,2020,5(5):CD012825.
[7] Wolf D,Ley K.Immunity and inflammation in atherosclerosis[J].Herz,2019,44(2):107-120.
[8] Dharmakidari S,Bhattacharya P,Chaturvedi S.Carotid artery stenosis: medical therapy, surgery, and stenting[J].Curr Neurol Neurosci Rep,2017,17(10):77.
[9] Pedro-Botet J.CEDA,inflammation,new therapeutic approaches,arteriosclerosis e inflamación.Nuevosenfoquesterapéuticos[J].Med Clin(Barc),2020,155(6):256-262.
[10] Pathak A,Agrawal A. Evolution of C-reactive protein[Z], 2019: 943.
[11] Zlibut A,Bocsan IC,Agoston-Coldea L.Pentraxin-3 and endothelial dysfunction[J].Adv Clin Chem,2019,91:163-179.
[12] Carrizzo A,Lenzi P,Procaccini C,et al.Pentraxin 3 induces vascular endothelial dysfunction through a p-selectin/matrix metalloproteinase-1 pathway[J].Circulation,2015,131(17):1495-1505; discussion 1505.
[13] Adam CA, �瘙 塁 alaru DL,Prisacariu C,et al.Novel biomarkers of atherosclerotic vascular disease-latest insights in the research field[J].Int J Mol Sci,2022,23(9):4998.
[14] Yan XJ,Gao J,Tang M,et al.Combined assessment of elevated plasma lipoprotein-associated phospholipase a2 and plaque enhancement improved accuracy in the risk of acute ischemic stroke in patients with intracranial artery stenosis[J].J Stroke Cerebrovasc Dis,2021,30(12):106103.
[15] 曹静.血清脂蛋白相关磷脂酶A2在急性缺血性脑卒中伴脑动脉狭窄中的临床价值[D].合肥:安徽医科大学,2021.
[16] Zhang S,Huang S,Hu D,et al. Biological properties and clinical significance of lipoprotein-associated phospholipase a2 in ischemic stroke[Z], 2022: 3328574.
[17] Bonnefont-Rousselot D.Lp-PLA2, a biomarker of vascular inflammation and vulnerability of atherosclerosis plaques[J].Ann Pharm Fr,2016,74(3):190-197.

相似文献/References:

[1]包正军,刘琳.急性脑梗死患者血清尿酸水平与颈动脉粥样硬化的关系研究[J].卒中与神经疾病杂志,2015,22(03):160.
[2]白文婷,杨丽荣,吕利英,等.多个危险因素聚集与急性缺血性脑卒中患者出院结局不良的关系[J].卒中与神经疾病杂志,2015,22(02):71.
[3]陈翠荣,赵振国,周媛,等.轻中度急性脑梗死MRI指导下超时间窗静脉溶栓治疗的研究[J].卒中与神经疾病杂志,2014,21(06):330.
[4]但毕堂,彭小祥,陈小奇,等.急性缺血性脑卒中时间窗内的动静脉溶栓分层治疗的对比研究[J].卒中与神经疾病杂志,2014,21(06):334.
[5]宗彦武,蔡柳燕,张岩.神经介入联合阿加曲班对急性缺血性脑卒中患者血清FIB,D-D表达水平的影响[J].卒中与神经疾病杂志,2022,29(04):365.[doi:10.3969/j.issn.1007-0478.2022.04.012]
[6]李海峰,李振华,刘丽娟.急性缺血性脑卒中患者血清Survivin,Hepc25水平变化及其临床意义[J].卒中与神经疾病杂志,2022,29(05):432.[doi:10.3969/j.issn.1007-0478.2022.05.007]
　Li Haifeng*,Li Zhenhua,Liu Lijuan*..Changes in serum Survivin and Hepc25 levels in patients with acute ischemic stroke and their clinical significance[J].Stroke and Nervous Diseases,2022,29(03):432.[doi:10.3969/j.issn.1007-0478.2022.05.007]
[7]秦雅鑫 任占云 李杰 许冬华 叶沈早 陈蒋楠.Willis环完整性和脑白质变化对急性缺血性脑卒中患者神经功能缺损及预后的影响[J].卒中与神经疾病杂志,2023,30(03):259.[doi:10.3969/j.issn.1007-0478.2023.03.005]
　Qin Yaxin,Ren Zhanyun,Li Jie,et al.Effects of Willis ring integrity and white matter changes on neurological deficit and prognosis in patients with acute ischemic stroke[J].Stroke and Nervous Diseases,2023,30(03):259.[doi:10.3969/j.issn.1007-0478.2023.03.005]
[8]顾亮亮 王建锋 乔鑫 张保朝 傅国惠.急性缺血性脑卒中患者静脉溶栓前后SCUBE1水平的变化及其与预后不良的相关性分析[J].卒中与神经疾病杂志,2023,30(03):265.[doi:10.3969/j.issn.1007-0478.2023.03.006]
　Gu Liangliang*,Wang Jianfeng,Qiao Xin*,et al.Changes of SCUBE1 levels after thrombolytic therapy in patients with acute ischemic stroke and its correlation with prognosis[J].Stroke and Nervous Diseases,2023,30(03):265.[doi:10.3969/j.issn.1007-0478.2023.03.006]
[9]王秋丽〓杨兴丹〓张航〓李国锋〓刘晨菲.伴与不伴脑动脉血管壁钙化的颈动脉粥样硬化患者的临床特征及预后分析[J].卒中与神经疾病杂志,2023,30(03):278.[doi:10.3969/j.issn.1007-0478.2023.03.009]
　Wang Qiuli,Yang Xingdan,Zhang Hang,et al.Differences in clinical characteristics and prognosis of patients with carotid atherosclerosis with and without cerebral artery vascular wall calcification[J].Stroke and Nervous Diseases,2023,30(03):278.[doi:10.3969/j.issn.1007-0478.2023.03.009]
[10]龚汉贤,庄泽微,李述桃,等.球囊导引导管在老年急性缺血性脑卒中患者取栓治疗中的作用[J].卒中与神经疾病杂志,2024,(01):73.[doi:10.3969/j.issn.1007-0478.2024.01.012]

备注/Memo

备注/Memo:
基金项目:湖北省卫计委(WJ2019M055); 国药东风总医院院内项目(2021S02)
更新日期/Last Update: 2023-06-20